Showing results (131-140 of 162) with videos related to
Sort By:
Pageof 17
Klinische Wochenschrift|April 17, 1989
Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995H S Füessl, W G Zoller, M M Kochen, et al.Antiviral Therapy|May 1, 2001
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trialJ R Bogner, M Roecken, D B Herrmann, et al.Gene Therapy|June 11, 2010
MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assaysS Kutscher, S Allgayer, C J Dembek, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 17, 1998
HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressorsR Walli, B Reinhart, B Luckow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study GroupS Stewart, H Jablonowski, F D Goebel, et al.International Journal of STD & AIDS|March 10, 2001
Participants in HIV clinical trials in EuropeW Schrooten, M Borchert, C Dreezen, et al.AIDS (London, England)|December 1, 1993
Brain HMPAO-SPECT and ocular microangiopathic syndrome in HIV-1-infected patientsS A Geier, E Schielke, K Tatsch, et al.Nuklearmedizin. Nuclear Medicine|October 1, 1988
[The place of 67Ga scintigraphy in the primary diagnosis and follow-up evaluation of opportunistic pneumonia in patients with AIDS]K Tatsch, P Knesewitsch, C M Kirsch, et al.The British Journal of Dermatology|July 1, 1988
T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi's sarcoma in AIDSP Spornraft, M Fröschl, J Ring, et al.AIDS (London, England)|November 14, 1998
Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patientsR Walli, O Herfort, G M Michl, et al.Pageof 17